Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Once finalized, cough syrups will no longer be available for over-the-counter sale
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The product will be marketed by Dr. Reddy's Laboratories Inc.
Subscribe To Our Newsletter & Stay Updated
